Immediate Impact

48 standout
Sub-graph 1 of 22

Citing Papers

Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets
2025 Standout
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
2025 Standout
2 intermediate papers

Works of Chris Ward being referenced

Predictors of quality of life in allogeneic hematopoietic stem cell transplantation survivors
2021
MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT‐737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment
2018

Author Peers

Author Last Decade Papers Cites
Chris Ward 118 17 31 84 58 7 233
Elena Rancan 67 2 34 103 105 9 233
Anne Marie Clement 95 16 47 204 117 8 270
Y. Gruel 180 1 26 43 46 13 239
Géraldine Lissalde-Lavigne 88 1 17 36 35 11 144
Paulien G. de Jong 118 19 79 84 11 279
C. Downey 62 6 18 25 27 9 200
Priya Patel 32 22 50 20 18 10 229
Teresa Maria Caimi 150 1 44 47 28 11 286
Sarah Barsam 107 21 37 93 100 8 260
Paul Brons 178 13 31 16 26 10 244

All Works

Loading papers...

Rankless by CCL
2026